R
ReLyfe
Platform for communication and sharing of medical information between patients and healthcare professionals
At a glance
- Status
- Operational
- Founded
- 2016
- Headquarters
- Reims, France
- Open positions
- None listed
- Dealroom signal
- 54.8/100
- Industry
- Health
- Sub-industry
- Health Platform
- Sector
- Health Tech & Medtech, Tech for Medical Professionals, Tech for Patients, Digital Care, observatoire healthtech
- Technology
- Artificial Intelligence, Big Data, Machine Learning, Deep Learning, Mobile app
- Client focus
- b2b, b2c
- Investment activity
- 1 company, latest May 2021
- Capital deployed
- —
- Preferred round
- ACQUISITION
- Links
- Website
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES A✓Equity / VC | May 2021 | $44M | $83M | Forepont Capital Partners | — |
Growth signals
Latest recorded traffic for ReLyfe is 230 monthly website visits, down 79.1% over the last three months.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A1 investor entered at this stage
Forepont Capital Partners
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about ReLyfe on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See ReLyfe’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.








